lyophilized powder raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-03-08 and is reviewed periodically as new material appears.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Peptide fragment | Corresponds to hGH residues 176-191 |
| Common synonyms | AOD9604, hGH 176-191 | Also written as AOD-9604 |
| Typical form | Lyophilized powder | Often supplied in sealed vials |
| Solubility | Water-soluble | Dissolves in aqueous buffers |
| Regulatory status | Not approved as drug | Banned in sport; varies by country |
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
The term fish processing refers to the processes associated with fish and fish products between the time fish are caught or harvested, and the time the final product is delivered to the customer. Although the term refers specifically to fish, in practice it is extended to cover any aquatic organisms harvested for commercial purposes, whether caught in wild fisheries or harvested from aquaculture or fish farming. Larger fish processing companies often operate their own fishing fleets or farming operations. The products of the fish industry are usually sold to grocery chains or to intermediaries. Fish are highly perishable. A central concern of fish processing is to prevent fish from deteriorating, and this remains an underlying concern during other processing operations. Fish processing can be subdivided into fish handling, which is the preliminary processing of raw fish, and the manufacture of fish products. Another natural subdivision is into primary processing involved in the filleting and freezing of fresh fish for onward distribution to fresh fish retail and catering outlets, and the secondary processing that produces chilled, frozen and canned products for the retail and catering trades. There is evidence humans have been processing fish since the early Holocene. These days, fish processing is undertaken by artisan fishermen, on board fishing or fish processing vessels, and at fish processing plants.
Smithfield hams are a specific variety of country hams which are cured by the long-cure, dry salt method and aged for a minimum period of six months within the limits of the town of Smithfield, Virginia, United States Soppressata – an Italian dry salami. Two principal types are made, a cured dry sausage typical of Basilicata, Apulia and Calabria, and a very different uncured salami, native to Tuscany and Liguria. Speck – in parts of the English-speaking culinary world, the term "Speck" refers to Italian Speck, a type of prosciutto. Speck is also an English word meaning "fat" or "blubber", attested since the early 17th century. Suho meso – a smoked beef food preparation eaten in Bosnian cuisine and Serbian cuisine. Sukuti – the Nepali word for dry meat (jerky). Sukuti is either consumed directly or charbroiled and spiced as an appetizer or snack or mixed with other ingredients and served as side dish.
To help prevent counterfeiting of currency, or forgery of important documents such as driver's licenses and passports, the paper may include a UV watermark or fluorescent multicolor fibers that are visible under ultraviolet light. Postage stamps are tagged with a phosphor that glows under UV rays to permit automatic detection of the stamp and facing of the letter. UV fluorescent dyes are used in many applications (for example, biochemistry and forensics). Some brands of pepper spray will leave an invisible chemical (UV dye) that is not easily washed off on a pepper-sprayed attacker, which would help police identify the attacker later. In some types of nondestructive testing UV stimulates fluorescent dyes to highlight defects in a broad range of materials. These dyes may be carried into surface-breaking defects by capillary action (liquid penetrant inspection) or they may be bound to ferrite particles caught in magnetic leakage fields in ferrous materials (magnetic particle inspection).
== Reactions == Fraser stated in July 2023 that over five hundred athletes had contacted him asking for more information. In August, D'Souza said that he had 500 "sleeper athletes" who are "breaking world records in their basement and sending us videos of it" ready for competition. In February 2024, he said that thousands of athletes interested in participating had contacted him. CNN reported in October 2023 that no athletes had publicly committed to the event; however, by early 2026, several high-profile international competitors, including former world champion James Magnussen and British swimmer Emily Barclay, had expressed interest or confirmed their participation.
Some medical organizations take the position that it carries prophylactic health benefits that outweigh the risks, while others hold that its medical benefits are not sufficient to justify it. Circumcision is one of the world's most common and oldest medical procedures, with 37–39% of men globally circumcised. Prophylactic usage originated in England during the 1850s and has since spread globally, becoming established as a way to prevent sexually transmitted infections. Beyond use as a prophylactic or treatment option in healthcare, circumcision plays a major role in many of the world's cultures and religions, most prominently Judaism and Islam. Circumcision is among the most important commandments in Judaism and considered obligatory. In some African and Eastern Christian denominations male circumcision is required. It is widespread in the United States, South Korea, the Philippines, Israel, Muslim-majority countries, and most of Africa. It is relatively rare for non-religious reasons in Latin America, Europe, Australia, most of Asia, and parts of Southern Africa. The origin of circumcision is not known with certainty, but the oldest documentation comes from ancient Egypt.
Sources: en.wikipedia.org
== Primary chloroplast lineages == All primary chloroplasts belong to one of four chloroplast lineages—the glaucophyte chloroplast lineage, the rhodophyte ("red") chloroplast lineage, the chloroplastida ("green") chloroplast lineage, and the amoeboid Paulinella chromatophora lineage. The glaucophyte, rhodophyte, and chloroplastidian lineages are all descended from the same ancestral endosymbiotic event and are all within the group Archaeplastida.
In 18th-century Europe, it is estimated that 400,000 people died from the disease per year, and that one-third of all cases of blindness were due to smallpox. Smallpox is estimated to have killed up to 300 million people in the 20th century and around 500 million people in the last 100 years of its existence. Earlier deaths included multiple European monarchs. As recently as 1967, 15 million cases occurred a year. Inoculation for smallpox appears to have started in China around the 1500s. Europe adopted this practice from Asia in the first half of the 18th century. In 1796, Edward Jenner introduced the modern smallpox vaccine. In 1967, the World Health Organization intensified efforts to eliminate the disease. Smallpox is one of two infectious diseases to have been eradicated, the other being rinderpest (a disease of even-toed ungulates) in 2011. The term "smallpox" was first used in England in the 16th century to distinguish the disease from syphilis, which was then known as the "great pox". Other historical names for the disease include pox, speckled monster, and red plague.
Given that the version of the theory we are testing is universalistic in its claims – that 'hegemony leads to balance … through all of the centuries we can contemplate' – case selection is unimportant. Any significant counterexample falsifies the universal claim; eight such examples demolish it. Wohlforth et al. state that systemic hegemony is likely under two historically common conditions: First when the rising hegemon develops the ability to incorporate and effectively administer conquered territories. And second, when the boundaries of the international system remain stable, and no new major powers emerge from outside the system. When the leading power can administer conquests effectively so they add to its power and when the system's borders are rigid, the probability of hegemony is high. The argument of universal reproduction of anarchy can be correct in the European context, "whereas a systematic survey of world history reveals that multipolarity has frequently given way to unipolarity or hegemony." Henry Kissinger, historian by profession, noted that "theories of the balance of power often leave the impression that it is the natural form of international relations. In fact, balance-of-power systems have existed only rarely in history." Yet based on these rare occurrences, many realists "elevate a fact of life … into a guiding principle of world order." Earlier, political scientist Martin Wight had drawn a conclusion with unambiguous implication for the modern world:
The first Lower Saxon parliament or Landtag met on 9 December 1946. It was not elected; rather it was established by the British Occupation Administration (a so-called "appointed parliament"). That same day the parliament elected the Social Democrat, Hinrich Wilhelm Kopf, the former Hanoverian president (Regierungspräsident) as their first minister-president. Kopf led a five-party coalition, whose basic task was to rebuild a state afflicted by the war's rigours. Kopf's cabinet had to organise an improvement of food supplies and the reconstruction of the cities and towns destroyed by Allied air raids during the war years. Hinrich Wilhelm Kopf remained – interrupted by the time in office of Heinrich Hellwege (1955–1959) – as the head of government in Lower Saxony until 1961. The greatest problem facing the first state government in the immediate post-war years was the challenge of integrating hundreds of thousands of refugees from Germany's former territories in the east (such as Silesia and East Prussia), which had been annexed by Poland and the Soviet Union. Lower Saxony was at the western end of the direct escape route from East Prussia and had the longest border with the Soviet Zone. On 3 October 1950 Lower Saxony took over the sponsorship of the very large number of refugees from Silesia. In 1950 there was still a shortage of 730,000 homes according to official figures.
Dread Central writer Jay Krieger found that monsters that were "reflective of their singularly unique worlds" were more memorable to him, and felt that there were few better examples of this than the Headcrab. He felt that the zombification they induced was evocative of John Carpenter's The Thing rather than George A. Romero's zombie films. He found the Half-Life 2 iteration of the Headcrab Zombies as particularly shocking, citing how the Headcrab Zombies have muffled screams from the host and, when killed, the Headcrab falls off dead, revealing a face recognizable enough to see the "haunted look of them realizing their fate in their final moments remains". He argued that the zombies of Half-Life served to show the humanity of the Headcrabs' victims. He also believed that the Headcrabs in Ravenholm, particularly the Poison Headcrabs and running zombies, represented how big of a threat Headcrabs could be. Edge staff felt that the running zombie was a memorable video game monster, believing that its "demented wail" was among the most chilling noises in video games. The Headcrab Zombies were described as "walking tragedies" by Rock Paper Shotgun writer Alec Meer, believing that they represented the horror of what zombies are rather than what zombies can do to the player. He appreciated how the game managed to escalate from questioning why the "weak, tiny" Headcrabs were attacking people, to seeing corpses twitching, and finally to seeing someone who was probably still alive but with no control of their body.
Sources: en.wikipedia.org
AOD-9604 is a synthetic peptide fragment of human growth hormone, corresponding to amino acids 176-191. It is studied for potential effects on fat metabolism, but it is not approved as a drug in most countries. Its exact mechanism remains under investigation.
No, it is a small fragment of the full growth hormone protein. It does not appear to stimulate growth or increase growth hormone levels in the same way. Its actions are thought to be more limited to metabolic pathways.
Regulatory status varies. It is not approved for medical use in the United States or many other countries. It is banned in sport by WADA, and its sale as a supplement or research chemical may be subject to legal restrictions.
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.